EXODUSPOINT CAPITAL MANAGEMENT, LP – BioCryst Pharmaceuticals, Inc. Transaction History
EXODUSPOINT CAPITAL MANAGEMENT, LP portfolio value:
$8.93M
portfolio value
EXODUSPOINT CAPITAL MANAGEMENT, LP quarter portfolio value change:
+19.09%
quarter
BioCryst Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +0.05% | 366 shares | 1.43M | $12.6 | 709.28K |
| Q2 2022 | share | Increase | 0.00% | 708.91K shares | 7.5M | $10.58 | 708.91K |
| Q1 2022 | share | Decrease | -100.00% | -120.82K shares | -1.67M | $16.26 | 0 |
| Q4 2021 | share | Increase | +185.68% | 78.53K shares | 1.06M | $13.79 | 120.82K |
| Q3 2021 | share | Decrease | -65.22% | -79.30K shares | -1.31M | $14.37 | 42.29K |
| Q2 2021 | share | Increase | 0.00% | 121.60K shares | 1.92M | $15.81 | 121.60K |
| Q3 2020 | share | Decrease | -100.00% | -35.96K shares | -171K | $3.44 | 0 |
| Q2 2020 | share | Increase | 0.00% | 35.96K shares | 171K | $4.76 | 35.96K |